The Devil Is in the Details: The Pharmaceutical Industry's Use of Gifts to Physicians as Marketing Strategy

Journal of Surgical Research

Volumn 140, Issue 1, 2007, Pages 1-5

  McFadden, David W ^a   Calvario, Elizabeth ^b   Graves, Cynthia ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Waynesburg College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; GOVERNMENT REGULATION; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; MEDICAL DECISION MAKING; MEDICAL PROFESSION; MEDICAL RESEARCH; MEDICAL SOCIETY; MEDICAL STUDENT; PHYSICIAN; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; RESIDENT;

DRUG INDUSTRY; GIFT GIVING; HUMANS; MARKETING OF HEALTH SERVICES; PHYSICIANS;

EID: 34247626364     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.10.010     Document Type: Article

References (35)

1. Dana J., and Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA 290 (2003) 252
2. Blumenthal D. Doctors and drug companies. N Engl J Med 351 (2004) 1885
3. Novak V. How drug companies operate on the body politic. Business Soc Rev (1993) 58 Winter
4. Antonuccio D., Danton W., and McClanahan T. Psychology in the prescription era. Am Psychol (2003) 1028 December
5. Reist D., and VandeCreek L. The pharmaceutical industry's use of gifts and educational events to influence prescription practices: ethical dilemmas and implications for psychologists. Prof Psych Res Pract 35 (2004) 329
6. Brennan T., Rothman D., Blank L., et al. Health industry practices that create conflicts of interest. JAMA 295 (2006) 429
7. Kotler P., and Keller K. Marketing Management. (12th ed). (2006), Pearson, Prentice, and Hall, Upper Saddle River (NJ)
8. Sierles F., Brodkey A., Cleary L., et al. Medical students' exposure to and attitudes about drug company interactions. JAMA 294 (2005) 1034
9. Gatti J. Over half of online physicians participating in e-detailing. Direct Marketing (2003) November 1
10. Williams S. Food for thought: why physicians should reconsider gifts from pharmaceutical companies. Curr Surg 60 (2003) 152
11. Day M. Industry association suspends drug company for entertaining doctors. Br Med J 332 (2006) 381
12. Kaiser Family Foundation. National Survey of Physicians, Part 2. Doctors and Prescription Drugs (2002) March
13. Chren M. Interactions between physicians and drug company representatives. Am J Med 107 (1999) 182
14. McKinney W., Schiedermayer D., Lurie N., et al. Attitudes of internal medicine faculty and residents towards professional interaction with pharmaceutical sales representatives. JAMA 264 (1990) 1693
15. Abbasi K., and Smith R. No more free lunches. Br Med J 326 (2003) 1155
16. Lexchin A., Bero L., Djulbegovic B., et al. Pharmaceutical industry sponsorship and research outcome. Br Med J 326 (2003) 1167
17. Chew L. A physician survey of the effects of drug sample availability on physicians' behavior. J Gen Int Med 7 (1998) 478
18. Studdert D., Mello M., and Brennan T. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry-self-regulation in the shadow of federal prosecution. N Engl J Med 351 (2004) 1891
19. Brett A., Burr W., and Moloo J. Are gifts from pharmaceutical companies ethically problematic?. Arch Int Med 163 (2003) 2213
20. Wofford J., and Ohl C. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes. Med Educ 5 (2005) 1
21. Moynihan R. Who pays for the pizza?. Redefining the relationships between doctors and drug companies. Br Med J 326 (2003) 1193
22. Grant D., and Iserson K. Who's buying lunch: are gifts to surgeons from industry bad for patients?. Thorac Surg Clin 15 (2005) 533
23. Wager E. How to dance with porcupines: rules and guidelines on doctor's relations with drug companies. Br Med J 326 (2003) 1196
24. Pa. hospital bans industry gifts. AMA News 5 (2006) 11
25. Schneider J., Arora V., Kasza K., et al. Residents' perceptions over time of pharmaceutical industry and gifts and the effect of an educational intervention. Acad Med 81 (2006) 7
26. Komesaroff P. Ethical issues in the relationships with industry: an ongoing challenge. J Paediatr Child Health 41 (2005) 558
27. Panush R. Why I no longer accept pens (or other gifts) from industry (and why you shouldn't either). J. Rheumatol 31 (2004) 1478
28. Halperin E., Hutchison P., and Barrier R. A population-based study on the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers. Int J Radiat Oncol Biol Phys 59 (2004) 1477
29. Watson P., Khandelwal A., Musial J., et al. Resident and faculty perceptions of conflict of interest in medical education. J Gen Int Med 20 (2005) 357
30. Rawlins M. Doctors and the drug makers. Lancet 2 (1984) 276
31. Kelly P. Marketing vital to health care. Advertising Age 75 (2004) 28
32. Rose R. The true colors of physicians. Med Marketing Media 3 (2004) 57
33. Chimonas S., and Rothman D. New federal guidelines for physician-pharmaceutical industry relations: the politics of policy formation. Health Affairs 24 (2005) 949
34. Office of Inspector General. Compliance program guidance for pharmaceutical manufacturers. Federal Register 68 (2003) 23731
35. Romano M. Fighting graft-it's academic. Mod Healthcare 36 (2006) 8